AC-262536 is a drug developed by Acadia Pharmaceuticals that acts as a selective androgen receptor modulator (SARM). Chemically, it exhibits endo-exo isomerism, with the endo form being the biologically active form.
It acts as a partial agonist of the androgen receptor with a binding affinity (Ki) of 5 nM. In addition, it shows no significant affinity for other receptors studied.
In animal studies, AC-262536 has shown a maximum anabolic effect that is approximately 66% of the anabolic potency of testosterone, and only approximately 27% of the androgenic potency of testosterone.
CONCENTRATION 10 mg / ml.
DISCLAIMER This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary or household use. Familiarize yourself with our DISCLAIMER before ordering.
Store at room temperature, tightly closed, away from heat, light and moisture.
Solubility
Soluble in DMSO
Organoleptic profile
Clear liquid
Physical form
Solution in DMSO, PEG400
Specification
10mg/mL ±5%
Terms and conditions
This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary or household use. Familiarize yourself with our DISCLAIMER before ordering.
